Patient Corner

Anatomical Illustrations


Latest drug updates

  • 8 Nov 2017 - Drug Updates

Do not use Solu-Medrone 40 mg in patients with a known or suspected allergy to cows’ milk

Stop administration of product if any allergic symptoms occur and treat patient’s condition accordingly.

  • 8 Nov 2017 - Drug Updates

Gabapentin (Neurontin): Risk of developing respiratory depression without concomitant use of opioids

Advise patients on gabapentin to seek medical help if they experience any trouble breathing or are taking shallow breaths.

  • 31 Oct 2017 - Drug Updates

Clozapine associated with risk of intestinal obstruction, faecal impaction, and paralytic ileus

Patients on antipsychotic drug clozapine are advised to report and treat constipation immediately.

  • 31 Oct 2017 - Drug Updates

Isotretinoin (Roaccutane): Risk of sexual side effects like erectile dysfunction and decreased libido

Healthcare professionals should be aware of sexual and psychiatric adverse reactions associated with Isotretinoin.

  • 28 Sep 2017 - Drug Updates

Loperamide (Imodium): Overdoses of loperamide associated with risk of serious cardiovascular events

Naloxone should be given as an antidote in case of overdoses of loperamide.

  • 28 Sep 2017 - Drug Updates

Patients on warfarin should not use over-the-counter Miconazole oral gel (Daktarin)

Patients on warfarin should take prescription-only miconazole oral gel and should seek immediate medical attention if they experience any signs of bleeding.

  • 23 Aug 2017 - Drug Updates

Local and systemic administration of corticosteroids: risk of central serous chorioretinopathy

Report any blurred vision or other visual disturbances during corticosteroid treatment.

  • 31 Jul 2017 - Drug Updates

Daclizumab (Zinbryta▼) in multiple sclerosis: Review patients for liver function currently on treatment

Initiate daclizumab in restricted groups of patients with limited treatment options and closely monitor liver function.

  • 28 Jul 2017 - Drug Updates

Nivolumab (Opdivo▼), pembrolizumab (Keytruda▼): Risk of graft rejection

Consider the benefit of treatment with nivolumab or pembrolizumab versus the risk of possible organ transplant rejection for each patient.

  • 27 Jun 2017 - Drug Updates

Yellow Card Scheme Website: Report any side effects or safety concerns with e-cigarettes and e-liquids

Information on Yellow Card Scheme Website can aid in identifying unrecognised side effects and can thereby help to support the safety of e-cigarettes.